You are here: Industry Insights > COVID-19

News List

UK’s chief medical officers upgrade coronavirus alert level pharmatimes
September 23, 2020
The chief medical officers for England, Scotland, Wales and Northern Ireland have recommended all four nations to upgrade their coronavirus alert levels from three to four following a rise in cases.
Seattle AVM Announces Second IND for AVM0703 for COVID-19, Influenza ARDS americanpharmaceuticalreview
September 23, 2020
AVM Biotechnology has received U.S. Food and Drug Administration (FDA) permission to proceed with clinical trials to evaluate its proprietary drug AVM0703 in the treatment of Acute Respiratory Distress Syndrome (ARDS) mediated by COVID-19 or Influenza ...
FDA Approves Study to Investigate Cell Therapy to Treat COVID-19 Related MIS-C americanpharmaceuticalreview
September 23, 2020
The Cura Foundation in collaboration with The Marcus Foundation, Sanford Health and Alliance for Cell Therapy Now, is supporting a clinical trial of human cord tissue mesenchymal stromal cells (hCT-MSC) to treat children with ...
FDA Publishes Comparative Performance Data for COVID-19 Tests americanpharmaceuticalreview
September 23, 2020
The U.S. Food and Drug Administration (FDA) has published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The tables show the Limit of Detection (LoD) of more than 55 authorized molecular diagnostic COVID-19 tests ...
Serum Institute starts manufacturing Codagenix’s COVID-19 vaccine candidate expresspharma
September 23, 2020
CDX-005, an intranasal, live-attenuated vaccine candidate, has completed preclinical animal studies, and Codagenix expects to initiate human trials by end of 2020.
Global pharma’s two battles – supply continuity and COVID-19 vaccine expresspharma
September 23, 2020
Richa Mahindru, Domain Leader, Pharma and Life Sciences Practice, Praxis Global Alliance and Ishani Jain, Member, Pharma and Life Sciences Practice, Praxis Global Alliance elaborate on how pharma companies are dealing with these twin challenges and ...
Researchers uncover early results about an existing tuberculosis vaccine that has been hypothesized to help against the coronavirus worldpharmanews
September 22, 2020
While scientists race to develop and test a vaccine effective against SARS-CoV-2, the virus that causes COVID-19, recent studies have indicated that countries with widespread BCG vaccination appear to be weathering the pandemic better than their ...
Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX facility worldpharmanews
September 22, 2020
64 higher income economies have joined the COVAX Facility, a global initiative that brings together governments and manufacturers to ensure eventual COVID-19 vaccines reach those in greatest need, whoever they are and wherever they live.
UK Prime Minister visits the UK Vaccines Manufacturing and Innovation Centre (VMIC) europeanpharmaceuticalreview
September 22, 2020
Prime Minister Boris Johnson visited the construction site of the VMIC and met scientists and engineers at the forefront of the UK’s COVID-19 response.
BenevolentAI's Platform-Derived Hypothesis for COVID-19 Treatment Validated in NIAID Trial americanpharmaceuticalreview
September 22, 2020
BenevolentAI has confirmed data released from a large scale randomized clinical trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), further validating its AI-derived hypothesis for baricitinib as a treatment for COVID-19